Stay updated on LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:43:57.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the study drug LY3484356 alone or in combination with other anticancer therapies for participants with advanced or metastatic breast cancer or endometrial cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:10.000Z thumbnail image
  7. Check
    15 days ago
    Change Detected
    Summary
    The change on the webpage represents an update in the estimated study completion date, which is now set for 2027-12. This change may indicate a shift in the timeline for the research study related to advanced or metastatic breast cancer and endometrial cancer.
    Difference
    0.0%
    Check dated 2024-06-01T11:20:17.000Z thumbnail image
  8. Check
    16 days ago
    Change Detected
    Summary
    The value 03 26 2024 -31 03 25 03 26 03 has recently changed to 05 30 2027 05 29 (Estimated) 05 30 05 on the webpage. This change represents an update in the estimated study completion date for the clinical trial investigating the drug LY3484356 in participants with advanced or metastatic breast cancer or endometrial cancer.
    Difference
    0.8%
    Check dated 2024-05-31T10:14:36.000Z thumbnail image
  9. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, such as the requirement to provide an archival tissue sample and use highly effective birth control, along with specific inclusion and exclusion criteria for different parts of the study.
    Difference
    20%
    Check dated 2024-05-22T20:55:39.000Z thumbnail image
  10. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:14:50.000Z thumbnail image

Stay in the know with updates to LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.